Circassia Pharmaceuticals PLC (LSE:CIR) - Share price


Stock Report

Circassia Pharmaceuticals PLC CIR

Last Price
GBX17.09

Day Change
-0.01|-0.06%

As of 21/11/2019
14:09:40 GMT | GBX
Minimum 15 Minutes Delay.

Last Close17.10p
Day Range16.45 - 17.35
Mkt Cap64.16Mil
52-Wk Range13.25 - 66.60
Yield %-
ISINGB00BJVD3B28
Volume1,129,173
P/E-1.84
P/S0.01
P/CF-0.01

Share Price

Total Returns 20/11/2019

 Chg (%)  
More ...
Circassia Pharmaceuticals PLC-0.44 
FTSE 100 TR GBP1.90
 
Financials
201620172018
More ...
Income Statement
Turnover23.1046.3048.30
Operating Profit-43.80-82.30-37.50
Net Profit-36.90-60.50-46.60
Reported EPS-13.00-19.00-14.00
Balance Sheet
Current Assets138.4089.9054.00
Non Current Assets195.70312.50253.40
Total Assets334.10402.40307.40
Current Liabilities21.5030.80124.40
Total Liabilities---
Total Equity280.70224.80125.90
Cash Flow
Operating Cash Flow-68.50-66.50-51.50
Net Change in Cash-72.70-54.00-4.70

Regulatory News

DateAuthor Headline
02/09/2019James Gard Director Changes at Woodford Patient Capital Trust
Steven Harris, who founded a firm that Woodford invested in will step down as non-executive director, to be replaced by Ruffer co-founder Jane Tufnell
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
30/09/2019PurchaseMr. Jonathan Charles Emms16.52300,00049,544.00

Company Profile

Circassia Pharmaceuticals PLC is a biotechnology company. It is engaged in the development and commercialization of range of therapies for asthma and chronic obstructive pulmonary disease.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 01/05/2020

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-30.44
Op Mrgn-0.78
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanDr. Francesco Granata
Executive Director, Chief Financial Officer and Company SecretaryJulien Cotta
Executive Director, Chief Executive OfficerMr. Steven Charles Andrew Harris
Executive DirectorMr. Jonathan Charles Emms
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.